| |
|
|
| General
Information |
Last Updated on 24/08/2010 |
|
CORPORATE
HISTORY :
| |
Year of Establishment (Initially as a Partnership) |
: |
1958 |
| |
Incorporated
as a Private Limited Company |
: |
1964 |
| |
Technical
Collaboration Agreement with Janssen Pharmaceuticals
of Belgium
(A subsidiary of Johnson & Johnson International
Ltd.) |
: |
1975 |
| |
Technical
Collaboration Agreement with F.Hoffman-La Roche &
Co. Ltd. |
: |
1984 |
| |
Converted
into Public Limited Company |
: |
1991 |
| |
Initially Public Offering (IPO) |
: |
1994 |
| |
Stock Exchange
Listing (Dhaka & Chittagong) |
: |
1995 |
| |
Agreement
with M/s. Bovis Tanvec Ltd. of UK for implementation
of Dhaka Plant |
: |
1996 |
| |
Awarded ISO-9001 Cerificate |
: |
1998 |
| |
Awarded UK-MHRA Certificate |
: |
2007 |
| |
Business
Lines |
: |
Manufacturing and Marketing of Pharmaceutical Finished Products, Basic Chemicals, AgroVet Products and Pesticide Products |
| |
Authorized
Capital |
: |
US$ 73.5 Million
(Tk. 5,000 Million) |
| |
Paid-up
Capital |
: |
(Tk. 1207.22 Million) |
| |
Number of
Employees |
: |
3,564 |
| |
Subsidiary Company |
: |
Square Cephalosporins Ltd.
Square Biotechs Ltd.
Square Multifabrics Ltd.
|
| |
Associate Company |
: |
Square Textiles Ltd.
Squar Knit Fabrics Ltd.
Square Fashions Ltd.
Square Hospitals Ltd.
|
|
|
|
| |
CORPORATE OPERATIONAL RESULT
|
| Figure
in thousand : BDT |
| |
2007-08 |
2006-07 |
2005-06 |
2004-05 |
2003-04 |
|
|
Turnover (Gross) |
9,565,716 |
8,711,035 |
7,085,553 |
6,199,135 |
5,482,088 |
|
Value Added Tax |
1,307,872 |
1,210,223 |
995,648 |
867,088 |
760,536 |
|
Turnover (Net) |
8,257,844 |
7,500,811 |
6,089,905 |
5,332,047 |
4,721,552 |
|
Gross Profit |
3,401,782 |
3,232,364 |
2,564,503 |
2,172,593 |
1,906,592 |
|
Net Profit before Tax |
1,868,634 |
1,722,906 |
1,533,043 |
1,513,019 |
1,151,636 |
|
Net Profit after Tax |
1,381,863 |
1,303,243 |
1,165,865 |
1,255,848 |
970,044 |
|
Shareholders Equity |
8,417,041 |
7,333,258 |
6,402,015 |
5,568,790 |
4,590,142 |
|
Total Assets |
12,703,127 |
10,486,940 |
9,298,987 |
7,907,933 |
6,021,497 |
|
Total Bank Borrowings |
3,569,280 |
2,536,524 |
2,334,925 |
1,902,331 |
988,611 |
|
Total Current Assets |
4,411,836 |
3,682,511 |
4,031,685 |
3,242,502 |
2,016,056 |
|
Total Current Liabilities |
3,500,845 |
2,555,566 |
2,260,755 |
1,949,949 |
1,250,676 |
|
Current Ratio |
1.26 |
1.44 |
1.78 |
1.66 |
1.62 |
|
| Figure
in thousand : US$ |
| |
2007-08 |
2006-07 |
2005-06 |
2004-05 |
2003-04 |
|
|
Turnover (Gross) |
140672.29
|
128103.45
|
100790 |
93997.49
|
93137.75 |
|
Value Added Tax |
19232.41 |
17797.39 |
14162.85 |
13147.65
|
12921.10 |
|
Turnover (Net) |
121438.88 |
11006.000 |
86627.38 |
80849.84
|
80216.65 |
|
Gross Profit |
50026.20 |
47534.76 |
36479.41 |
32943.03
|
32391.98 |
|
Net Profit before Tax |
27479.91 |
25336.85 |
21807.15 |
22941.91
|
19565.68 |
|
Net Profit after Tax |
20321.51 |
19165.33 |
16584.13 |
19042.42
|
16480.53 |
|
Shareholders Equity |
123780.01 |
107842.03 |
91067.06 |
84439.57
|
77984.06 |
|
Total Assets |
16810.69 |
154219.70 |
132275.77 |
119908.00
|
102302.02 |
|
Total Bank Borrowings |
52489.41 |
37301.82 |
33213.72 |
28845.04
|
16795.97 |
|
Total Current Assets |
64879.94 |
54154.57 |
57349.72 |
49166.06
|
34251.71 |
|
Total Current Liabilities |
51483.01 |
37581.85 |
32158.67 |
29567.08
|
21248.31 |
|
Current Ratio |
1.26 |
1.44 |
1.78 |
1.66 |
1.62 |
|
|
| |
2007-08 |
2006-07 |
2005-06 |
2004-05 |
2003-04 |
|
| No.
of Share Outstanding |
8,942,400 |
5,961,600 |
4,968,000 |
4,320,000 |
3600,000 |
| Dividend per Share(Cash) |
40 |
50 |
75 |
77 |
70
|
| Dividend per Share(Stock) |
35% |
50% |
20% |
15% |
20%
|
| Shareholders' Equity per Share |
941 |
1,230 |
1,289 |
1,289 |
1,063
|
| EPS at original capital at IPO |
690.93 |
651.62 |
582.93 |
627.92 |
485.02 |
| Earning
per Share (SPL) |
154.53 |
218.61 |
234.67 |
290.91 |
224.55
|
| Earning
per Share (Consolidated) |
170.28 |
244.60 |
272.65 |
303.55 |
233.29
|
| Quoted
Price per Share - DSE |
4,110 |
2,447 |
2,276 |
3,768 |
2,272 |
| Quoted
Price per Share - CSE |
4,107 |
2,462 |
2,289 |
3,766 |
2,316 |
| Price
Earning Ratio - DSE (Time) |
26.60 |
11.19 |
9.70 |
12.95 |
10.12
|
| Number
of Shareholders |
31,688 |
13,009 |
13,206 |
10,486 |
9,270
|
| |
|
|
|
|
|
| Human Resources : |
2007-08 |
2006-07 |
2005-06 |
2004-05 |
2003-04 |
| Executive |
1,525 |
1,242 |
1,143 |
949 |
895 |
| Staff |
1,110 |
913 |
796 |
740 |
686 |
| Workers |
929 |
846 |
764 |
705 |
661 |
|
|
